Skip to main content
NVDA+0.10%AAPL-0.10%GOOGL-1.24%MSFT0.00%AMZN+0.25%TSM+1.49%SPCX+1.89%META-0.36%AVGO-0.48%TSLA-0.14%LLY-2.54%BRK-B-0.87%MU+0.09%SKHY+4.05%WMT-1.02%JPM-1.47%AMD+1.74%V-1.55%XOM+2.79%JNJ-1.42%ASMLa-0.87%MA-1.52%ABBV+0.16%CVX+2.88%INTC+1.72%0700.HK+0.94%COST-1.46%1398.HK-1.50%CSCO+1.53%KO-2.76%ORCL+0.49%UNH-1.62%PG-2.76%BAC-1.02%1816.HK+0.44%3988.HK-0.50%HD-2.41%CAT-2.42%0005.HK-1.04%PM-1.13%HSBA.L-1.07%AP2d-0.03%0857.HK-0.93%0939.HK+0.51%AMAT+0.44%GE-2.69%1288.HK-1.94%DELL+0.77%LRCX-0.02%NVS-3.30%EURCAD+0.48%GBPTRY+0.41%CADCHF-0.40%GBPHKD+0.32%EURJPY+0.29%GBPMXN-0.28%USDCAD+0.28%GBPCAD+0.27%USDTHB-0.23%AUDCAD+0.22%CHFJPY+0.22%EURAUD+0.21%EURGBP+0.20%NZDCAD+0.20%EURUSD+0.18%EURNZD+0.18%NZDCHF-0.17%USDILS+0.16%AUDCHF-0.14%CADJPY-0.14%GBPCHF-0.13%USDCHF-0.13%USDJPY+0.12%AUDJPY+0.10%NZDJPY+0.07%USDTRY+0.06%GBPAUD+0.06%GBPJPY+0.05%EURCHF+0.05%USDCOP-0.04%GBPNZD+0.04%NZDUSD-0.04%GBPUSD-0.04%USDCNH+0.03%AUDUSD-0.03%AUDNZD-0.02%USDNOK0.00%USDPLN0.00%USDSEK0.00%USDZAR0.00%EURHKD0.00%USDDKK0.00%AUDNOK0.00%EURCNH0.00%EURZAR0.00%EURSEK0.00%AUDDKK0.00%CHFSEK0.00%USDHKD0.00%USDSGD0.00%EURSGD0.00%EURDKK0.00%GBPZAR0.00%GBPSGD0.00%NZDMXN0.00%EURNOK0.00%PLNJPY0.00%NZDSGD0.00%EURPLN0.00%EURCZK0.00%NOKJPY0.00%CHFSGD0.00%SGDJPY0.00%AUDSGD0.00%CHFNOK0.00%USDMXN0.00%GAGUSD0.00%XAGUSD0.00%HG10.00%S10.00%C10.00%XNGUSD0.00%USOIL0.00%W10.00%XAUUSD0.00%SUGAR0.00%COTTON0.00%COFFEE0.00%BTCUSD-0.39%ETHUSD+22.11%USDTUSD+0.02%XRPUSD+15.55%SOLUSD+15.78%TRXUSDT+0.52%ZECUSDT+0.62%DOGEUSD+20.76%XMRUSDT-2.29%LINKUSD+23.15%BCHUSDT+0.95%XLMUSD-1.54%UNIUSD+1.56%LTCUSD+17.32%SUIUSD-1.27%HBARUSDT-0.51%TONUSD+36.45%TAOUSDT+0.88%AAVEUSD-0.29%DOTUSDT-1.34%ICPUSDT-1.10%ONDOUSDT-0.72%WLDUSDT-3.10%ARBUSDT+0.38%JUPUSDT-2.29%ATOMUSDT+0.35%INJUSDT+2.72%STXUSDT-0.10%TIAUSDT-0.37%PYTHUSDT+4.65%FETUSDT-2.11%SEIUSDT-3.15%IMXUSDT-1.05%GRTUSDT-2.00%OPUSDT-1.73%IOTAUSDT-1.70%WIFUSDT-3.57%POLUSDT+0.09%AXSUSDT-1.91%EOSUSDT-3.12%FARTCOINUSDT-2.64%DYDXUSDT-2.78%GALAUSDT-2.36%ORDIUSDT-1.29%RONINUSDT-1.68%NOTUSDT-1.33%NVDA+0.10%AAPL-0.10%GOOGL-1.24%MSFT0.00%AMZN+0.25%TSM+1.49%SPCX+1.89%META-0.36%AVGO-0.48%TSLA-0.14%LLY-2.54%BRK-B-0.87%MU+0.09%SKHY+4.05%WMT-1.02%JPM-1.47%AMD+1.74%V-1.55%XOM+2.79%JNJ-1.42%ASMLa-0.87%MA-1.52%ABBV+0.16%CVX+2.88%INTC+1.72%0700.HK+0.94%COST-1.46%1398.HK-1.50%CSCO+1.53%KO-2.76%ORCL+0.49%UNH-1.62%PG-2.76%BAC-1.02%1816.HK+0.44%3988.HK-0.50%HD-2.41%CAT-2.42%0005.HK-1.04%PM-1.13%HSBA.L-1.07%AP2d-0.03%0857.HK-0.93%0939.HK+0.51%AMAT+0.44%GE-2.69%1288.HK-1.94%DELL+0.77%LRCX-0.02%NVS-3.30%EURCAD+0.48%GBPTRY+0.41%CADCHF-0.40%GBPHKD+0.32%EURJPY+0.29%GBPMXN-0.28%USDCAD+0.28%GBPCAD+0.27%USDTHB-0.23%AUDCAD+0.22%CHFJPY+0.22%EURAUD+0.21%EURGBP+0.20%NZDCAD+0.20%EURUSD+0.18%EURNZD+0.18%NZDCHF-0.17%USDILS+0.16%AUDCHF-0.14%CADJPY-0.14%GBPCHF-0.13%USDCHF-0.13%USDJPY+0.12%AUDJPY+0.10%NZDJPY+0.07%USDTRY+0.06%GBPAUD+0.06%GBPJPY+0.05%EURCHF+0.05%USDCOP-0.04%GBPNZD+0.04%NZDUSD-0.04%GBPUSD-0.04%USDCNH+0.03%AUDUSD-0.03%AUDNZD-0.02%USDNOK0.00%USDPLN0.00%USDSEK0.00%USDZAR0.00%EURHKD0.00%USDDKK0.00%AUDNOK0.00%EURCNH0.00%EURZAR0.00%EURSEK0.00%AUDDKK0.00%CHFSEK0.00%USDHKD0.00%USDSGD0.00%EURSGD0.00%EURDKK0.00%GBPZAR0.00%GBPSGD0.00%NZDMXN0.00%EURNOK0.00%PLNJPY0.00%NZDSGD0.00%EURPLN0.00%EURCZK0.00%NOKJPY0.00%CHFSGD0.00%SGDJPY0.00%AUDSGD0.00%CHFNOK0.00%USDMXN0.00%GAGUSD0.00%XAGUSD0.00%HG10.00%S10.00%C10.00%XNGUSD0.00%USOIL0.00%W10.00%XAUUSD0.00%SUGAR0.00%COTTON0.00%COFFEE0.00%BTCUSD-0.39%ETHUSD+22.11%USDTUSD+0.02%XRPUSD+15.55%SOLUSD+15.78%TRXUSDT+0.52%ZECUSDT+0.62%DOGEUSD+20.76%XMRUSDT-2.29%LINKUSD+23.15%BCHUSDT+0.95%XLMUSD-1.54%UNIUSD+1.56%LTCUSD+17.32%SUIUSD-1.27%HBARUSDT-0.51%TONUSD+36.45%TAOUSDT+0.88%AAVEUSD-0.29%DOTUSDT-1.34%ICPUSDT-1.10%ONDOUSDT-0.72%WLDUSDT-3.10%ARBUSDT+0.38%JUPUSDT-2.29%ATOMUSDT+0.35%INJUSDT+2.72%STXUSDT-0.10%TIAUSDT-0.37%PYTHUSDT+4.65%FETUSDT-2.11%SEIUSDT-3.15%IMXUSDT-1.05%GRTUSDT-2.00%OPUSDT-1.73%IOTAUSDT-1.70%WIFUSDT-3.57%POLUSDT+0.09%AXSUSDT-1.91%EOSUSDT-3.12%FARTCOINUSDT-2.64%DYDXUSDT-2.78%GALAUSDT-2.36%ORDIUSDT-1.29%RONINUSDT-1.68%NOTUSDT-1.33%
DT

Dianthus Therapeutics, Inc. (DNTH)

NASDAQ • Healthcare

$76.78
-$1.75 (-2.2%)
Market closed

Last close at October 23, 2026 at 20:00 UTC

Open$76.03
Day Range$76.02 - $78.16
Avg. Volume (3M)976K
Market Cap$4.2B
52 Week Range
$32.28$117.88

Metrics Over Time

Where the Money Goes

Q2 2026
Revenueeverything earned$761K100%
Gross Profitminus cost of goods$761K100%

Fundamentals & Financials

Revenue (TTM)
$1.9M
Net Income (TTM)
-$29.9M
EPS (TTM)
-$0.13
ROA (TTM)
-2.47%
Current Ratio
26.1

TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.

Earnings

-45.9%Q1 2026-$1.43
+27.4%Q2 2026-$0.85
-6.3%Q3 2026-$0.9

% — EPS deviation from the forecast (beat / miss); quarters without a forecast show the reported EPS

Latest report — Q3 2026
Miss -6.3%

Dianthus Therapeutics’ EPS trailed consensus in the fiscal second quarter of 2026, reported Aug. 4, even as revenue rose 294.3% to about $761,000. Operating income was a loss of about $61.5 million, and net income was a loss of about $50.2 million, down 58.8% from a loss of about $31.6 million a year ago. EPS of -$0.90 trailed the -$0.85 estimate, -6%, and was down 2.3% from -$0.88 a year ago. Consensus for the next period calls for EPS of -$1.02 on revenue of $400,833.00.

Next report — what to expect

Dianthus Therapeutics, Inc. (DNTH) is scheduled to report earnings on November 5, 2026. With consensus EPS and revenue not available here, attention may center on management updates and any changes in outlook. DNTH has beaten EPS in 3 of its 8 most recent quarters.

View full earnings history

About Dianthus Therapeutics, Inc.

Dianthus Therapeutics, Inc. is a NASDAQ-listed biotechnology company developing therapies for patients with severe autoimmune diseases. In qualitative terms, it is a clinical-stage healthcare company built around an early pipeline rather than commercialized products, with its work centered on two named candidates: claseprubart and DNTH212.

Name
Dianthus Therapeutics, Inc.
CEO
Marino Garcia
Website
dianthustx.com
Industry
Healthcare
Year Founded
2019
Employees
92

Today's Snapshot

AI-generated

DNTH closed 2.2% lower at 76.78, in line with a weaker sector. Trading was lighter than usual, with volume about a third of its usual level. DNTH reports earnings on 5 November.

Trading Volume

Below 10d avg (1.1M)

370.6K

vs S&P 500 Today

Underperforming Market

-1.71%

Updated: October 23, 2026 at 20:14 UTC

Technical Indicators

0 Buy3 Neutral5 Sell
DNTH shows a Strong Sell profile driven by a pronounced bearish trend and weakening momentum. The ADX is strong near 49, confirming trend dominance, while momentum and MACD readings are negative and RSI is down near the low 30s, indicating soft internals. Price is below most moving averages, including the 200-day, and on-balance volume aligns with selling pressure. Volatility is elevated with an ATR around $4.3, which amplifies downside moves. Technical takeaway: Strong Sell — clear downtrend with persistent selling pressure and elevated volatility.
All signals
  • EMA (5 indicators)$78.19 - $91.36
    Sell
  • RSI (14)32.60
    Neutral
  • Stochastic %K (14, 3, 3)41.10
    Neutral
  • MACD Level (12, 26)-5.52
    Neutral

Peers & Related Assets

IMVTImmunovant, Inc.
$28.41-2.4%
VERAVera Therapeutics, Inc.
$27.99-3.6%
ANABAnaptysBio, Inc.
$48.73+1.3%
ALMSAlumis Inc.
$6.78-0.6%
MLTXMoonLake Immunotherapeutics
ARTVArtiva Biotherapeutics, Inc.
Stay Ahead of the Market

Get premium market insights delivered directly to your inbox.